Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer-Reference-Cited by-同舟云学术

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer

Published:1997-01 Issue:1 Volume:8 Page:49-56
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fetscher S.,Brugger W.,Engelhardt R.,Kanz L.,Hasse J.,Frommhold H.,Wenger M.,Lange W.,Mertelsmann R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/1/49/19480160/8-1-49.pdf

Reference76 articles.

1. A prospective randomised study in limited disease small-cell carcinoma-doxorubicin and vincristin plus either cyclophosphamide or etoposide;Abratt;Eur J Cancer,1995

2. Determinants of improved outcome in small-cell lung cancer. An analysis of 2580 patients in the Southwest Oncology Group data base;Albain;J Clin Oncol,1990

3. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer;Arriagada;N Engl J Med,1993

4. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission;Arriagada;J Natl Cancer Inst,1995

5. Quality-of-life and cost-effectiveness assessment in lung cancer;Bergman;Curr Opin Oncol,1995

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Cell Lung Cancer: Therapies and Targets;Seminars in Oncology;2014-02

2. Sequential or concomitant chemotherapy in limited stage small-cell lung cancer;Swiss Medical Weekly;2011-05-31

3. Phase I Study of Fixed Dose Gemcitabine Plus Epirubicin in Patients With Advanced Solid Malignancies;American Journal of Clinical Oncology;2009-12

4. Small cell carcinoma originating from the cavernous sinus;Acta Neurochirurgica;2009-05-13

5. A Threefold Dose Intensity Treatment With Ifosfamide, Carboplatin, and Etoposide for Patients With Small Cell Lung Cancer: A Randomized Trial;JNCI Journal of the National Cancer Institute;2008-04-08